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Abstract 
 
Two different recombinant proteins representing region II of the Duffy Binding Protein of 
Plasmodium vivax, DBP and PvRII expressed in the bacculovirus and Eschericia coli vector 
systems, respectively, were compared by assaying the total immunoglobulin (IgM + IgG) 
responses of sera of patients with acute vivax malaria in an indirect ELISA. The patients were 
from two malaria endemic areas, Anuradhapura (n=64) and Kataragama (n=90), and a non-
endemic area, Colombo (n=90). 
 
The antibody prevalence was 50% and 44% from Anuradhapura, 39% and 28% Kataragama 
and 57% and 41% from Colombo, for PvRII and DBP, respectively. The antibody prevalence 
for  PvRII  was  higher  than  that  for  DBP  in  each  test  area,  that  was  significant  only  in 
Colombo (p=0.001). The percentages of patients that they responded to both proteins were 
34%  (n=22),  19%  (n=17)  and  40%  (n=36)  from  Anuradhapura,  Kataragama  and  from 
Colombo,  respectively.  In  comparison,  a  significantly  lower  (p=0.007)  percentage  of 
individuals  from  Kataragama  responded  to  both  proteins.  Further  16%  (n=10)  from 
Anuradhapura, 19% (n=17) from Kataragama and 16% (n=14) from Colombo preferentially 
recognised PvRII, whereas, corresponding values for DBP were 9% (n=6), 10% (n=9) and 
1% (n=1), respectively, where this difference was significant only in Colombo (p=0.031). 
Among the previously non-exposed patients from Colombo, 24% responded preferentially to 
PvRII whereas it was only 3% for DBP (p=0.021). On the other hand, of the previously 
exposed  patients  from  Colombo,  10%  preferentially  responded  to  PvRII  whereas  no 
preferential recognition of DBP was observed (p=0.063). 
 
Thus the results of this study show a higher natural antibody response to recombinant protein 
PvRII,  which  represents  the  functional  conformation  of  region  II  of  the  Duffy  Binding 
Protein. 
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